Back to search

Article

Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis

2025-04-16

Abstract excerpt

<h4>Background: </h4> /Objectives: Metabolic dysfunction-associated steatohepatitis (MASH), characterized by liver inflammation, fibrosis, and fat accumulation, can develop into cirrhosis and liver cancer. Despite its increasing prevalence worldwide, there are few established therapies for advanced MASH. We previously demonstrated that stem cells from human exfoliated deciduous teeth-conditioned media (SHED-CM) ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9902f20b-8fd2-5c37-859f-4f094e45a43d
DOI
10.20944/preprints202504.1368.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated SteatohepatitisDOI 10.20944/preprints202504.1368.v1
Select a neighboring publication to make it the new centre.